Complete Filing Data
New Mountain Finance Corp reported Net Asset Value Per Share of 12 shares for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean New Mountain Finance Corp did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | $16.5M | $113.4M | $135.3M | $74.7M | $201.4M | $58.5M |
| Other General And Administrative Expense | $1.8M | $2.0M | $2.1M | $2.3M | $1.9M | $1.8M |
| Net Income Loss Attributable To Noncontrolling Interest | $485.0K | $1.1M | $747.0K | -$204.0K | $5.8M | $3.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $12.2M | $7.8M | $23.4M | $23.9M | $34.5M | $27.4M | $28.7M | $34.8M | $44.6M | $7.7M | $16.0M | $36.2M | $21.8M | $79.2M | $51.9M |
| Other General And Administrative Expense | $478.0K | $331.0K | $516.0K | $531.0K | $527.0K | $465.0K | $542.0K | $513.0K | $488.0K | $545.0K | $518.0K | $477.0K | $490.0K | ||
| Net Income Loss Attributable To Noncontrolling Interest | $153.0K | $101.0K | $104.0K | $5.0K | $313.0K | $676.0K | $3.0K | $248.0K | $239.0K | -$191.0K | -$814.0K | $855.0K | $1.1M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $1.18B | $1.35B | $1.32B | $1.31B | $1.32B | $1.24B | $1.28B | |||||
| Guaranteed Debt | $196.2M | $300.0M | $300.0M | $300.0M | $300.0M | $300.0M | $225.0M | $165.0M | $150.0M | $121.7M | $117.7M | $37.5M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $80.7M | $80.3M | $70.1M | $71.2M | $58.1M | $79.0M | $48.6M | |||||
| Unsecured Debt | $991.6M | $978.5M | $506.5M | $531.5M | $511.5M | $453.3M | ||||||
| Repayments Of Unsecured Debt | $0.00 | $116.5M | $140.0M | $55.0M | $141.8M | $0.00 | ||||||
| Debt And Equity Securities Unrealized Gain Loss | -$162.6M | $15.7M | $10.3M | -$84.1M | $92.4M | -$53.7M | ||||||
| Debt And Equity Securities Realized Gain Loss | $43.2M | -$41.8M | -$32.9M | $52.7M | -$3.9M | -$2.8M | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $245.0K | $10.6M | -$1.2M | $13.5M | -$20.9M | $30.4M | ||||||
| Accretion Amortization Of Discounts And Premiums Investments | $8.8M | $7.4M | $6.3M | $5.6M | $8.6M | $10.3M | ||||||
| Retained Earnings Accumulated Deficit | -$121.7M | -$13.6M | -$12.3M | $7.5M | $47.5M | -$48.8M | ||||||
| Noncash Activity On Investments | $74.7M | $26.4M | $15.8M | $0.00 | $34.7M | $107.0M | ||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Other Assets | $17.9M | $19.3M | $16.5M | $9.8M | $11.1M | |||||||
| Minority Interest | $6.1M | $6.0M | $11.8M | $11.7M | $21.4M | |||||||
| Management Fee Payable | $9.2M | $10.5M | $10.1M | $10.5M | $10.2M | |||||||
| Long Term Debt | $1.67B | $1.84B | $1.79B | $1.98B | $1.91B | |||||||
| Liabilities And Stockholders Equity | $2.90B | $3.25B | $3.16B | $3.35B | $3.30B | |||||||
| Liabilities | $1.71B | $1.89B | $1.83B | $2.03B | $1.95B | |||||||
| Investment Owned Percent Of Net Assets | $2.31 | $2.27 | $2.26 | $2.43 | $2.36 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $1.26B | $1.31B | $1.34B | $1.36B | $1.37B | $1.36B | $1.33B | $1.33B | $1.33B | $1.33B | $1.37B | $1.37B | $1.30B | $1.31B | $1.26B |
| Guaranteed Debt | $196.2M | $262.5M | $262.5M | $300.0M | $300.0M | $300.0M | $300.0M | $300.0M | $300.0M | $300.0M | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $63.7M | $57.4M | $85.5M | $61.9M | $119.6M | $107.5M | $83.3M | $45.9M | $46.4M | $48.9M | $40.7M | $35.4M | $83.4M | ||
| Unsecured Debt | $991.0M | $990.0M | $985.2M | $993.6M | $686.0M | $686.7M | $391.5M | $391.5M | $441.5M | $531.5M | |||||
| Repayments Of Unsecured Debt | $0.00 | $116.5M | $90.0M | $0.00 | |||||||||||
| Debt And Equity Securities Unrealized Gain Loss | -$49.1M | $3.0M | $5.9M | -$9.9M | |||||||||||
| Debt And Equity Securities Realized Gain Loss | $37.8M | -$11.8M | $665.0K | $19.2M | |||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $5.3M | $37.5M | -$24.8M | -$22.6M | |||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $1.6M | $1.8M | $1.6M | $1.4M | |||||||||||
| Retained Earnings Accumulated Deficit | -$73.0M | -$51.4M | -$24.7M | -$38.2M | -$25.4M | -$23.2M | $11.7M | $19.3M | $19.8M | $17.2M | |||||
| Noncash Activity On Investments | $61.0M | $20.3M | $15.6M | $0.00 | |||||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Other Assets | $17.8M | $34.5M | $18.8M | $19.2M | $28.5M | $17.4M | $22.3M | $13.9M | $11.3M | $11.3M | |||||
| Minority Interest | $6.0M | $6.0M | $6.0M | $6.3M | $12.4M | $12.3M | $11.7M | $11.9M | $11.8M | $13.1M | |||||
| Management Fee Payable | $9.6M | $9.8M | $9.9M | $10.7M | $10.5M | $10.1M | $10.3M | $10.5M | $10.6M | $10.6M | |||||
| Long Term Debt | $1.77B | $1.77B | $1.78B | $1.99B | $1.94B | $1.75B | $1.89B | $1.91B | $1.99B | $1.96B | |||||
| Liabilities And Stockholders Equity | $3.09B | $3.16B | $3.20B | $3.41B | $3.42B | $3.26B | $3.28B | $3.30B | $3.38B | $3.35B | |||||
| Liabilities | $1.83B | $1.85B | $1.85B | $2.05B | $2.04B | $1.89B | $1.94B | $1.96B | $2.04B | $2.00B | |||||
| Investment Owned Percent Of Net Assets | $2.33 | $2.29 | $2.25 | $2.39 | $2.32 | $2.24 | $2.33 | $2.38 | $2.44 | $2.40 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Proceeds From Issuance Of Common Stock | $0.00 | $67.7M | $21.2M | $40.0M | $12.4M | $0.00 |
| Payments To Minority Shareholders | $358.0K | $925.0K | $693.0K | $9.6M | $1.2M | $0.00 |
| Payments Of Stock Issuance Costs | $76.0K | $444.0K | $409.0K | $204.0K | $205.0K | $278.0K |
| Payments Of Dividends Common Stock | $135.7M | $147.2M | $150.7M | $121.3M | $114.2M | $120.1M |
| Payments Of Debt Issuance Costs | $2.6M | $11.7M | $11.9M | $4.2M | $10.2M | $4.9M |
| Net Cash Provided By Used In Operating Activities | $379.0M | $42.0M | $332.7M | $35.0M | -$22.1M | $301.1M |
| Net Cash Provided By Used In Financing Activities | -$378.7M | -$31.4M | -$333.9M | -$21.5M | $1.2M | -$270.7M |
| Increase Decrease In Other Operating Liabilities | -$139.0K | -$349.0K | -$272.0K | $397.0K | $479.0K | $321.0K |
| Increase Decrease In Other Operating Assets | -$1.4M | $2.9M | $6.6M | -$1.3M | $5.1M | $2.1M |
| Increase Decrease In Management Fee Payable | -$1.3M | $351.0K | -$408.0K | $360.0K | -$255.0K | $121.0K |
| Increase Decrease In Interest Payable Net | -$5.2M | -$3.2M | $813.0K | $2.2M | $1.8M | -$897.0K |
| Increase Decrease In Interest And Dividends Receivable | -$3.8M | -$1.8M | $7.9M | $5.3M | $2.5M | -$3.4M |
| Increase Decrease In Incentive Fee Payable | -$5.6M | $70.0K | $2.3M | -$1.2M | $149.0K | -$292.0K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $153.0K | -$409.0K | $55.0K | -$391.0K | -$32.0K | $0.00 |
| Proceeds From Issuance Of Unsecured Debt | $0.00 | $595.0M | $115.0M | $75.0M | $200.0M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Proceeds From Issuance Of Common Stock | $0.00 | $47.9M | $0.00 | $20.5M |
| Payments To Minority Shareholders | $90.0K | $197.0K | $153.0K | $3.8M |
| Payments Of Stock Issuance Costs | $75.0K | $117.0K | $17.0K | $21.0K |
| Payments Of Dividends Common Stock | $34.5M | $38.3M | $32.3M | $28.5M |
| Payments Of Debt Issuance Costs | $1.4M | $4.0M | $1.2M | $14.0K |
| Net Cash Provided By Used In Operating Activities | $103.9M | $68.3M | -$3.5M | -$45.2M |
| Net Cash Provided By Used In Financing Activities | -$98.6M | -$30.8M | -$21.3M | $22.5M |
| Increase Decrease In Other Operating Liabilities | $1.2M | -$78.0K | -$403.0K | -$58.0K |
| Increase Decrease In Other Operating Assets | -$454.0K | $922.0K | $1.5M | $4.3M |
| Increase Decrease In Management Fee Payable | -$522.0K | -$20.0K | $51.0K | $10.5M |
| Increase Decrease In Interest Payable Net | $1.4M | $2.6M | $939.0K | -$7.2M |
| Increase Decrease In Interest And Dividends Receivable | -$1.2M | -$949.0K | -$1.9M | $3.9M |
| Increase Decrease In Incentive Fee Payable | -$1.9M | $834.0K | $3.3M | $7.5M |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | -$142.0K | -$99.0K | $37.0K | -$78.0K |
| Proceeds From Issuance Of Unsecured Debt | $0.00 | $297.0M | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Net Asset Value Per Share | $11.52 | $12.55 | $12.87 | $13.02 | $13.49 | $12.62 | $13.26 | $13.22 | $13.63 |
| Weighted Average Number Of Shares Outstanding Basic | 106.2M | 106.6M | 101.1M | 100.2M | 97.0M | 96.8M | 85.2M | 76.0M | |
| Common Stock Shares Outstanding | 102.6M | 107.9M | 102.6M | 100.9M | 97.9M | 96.8M | 96.8M | 76.1M | |
| Weighted Average Number Of Diluted Shares Outstanding | 121.1M | 125.5M | 123.5M | 115.4M | 110.2M | 110.1M | |||
| Earnings Per Share Diluted | $0.16 | $1.03 | $1.24 | $0.74 | $1.91 | $0.60 | |||
| Earnings Per Share Basic | $0.16 | $1.06 | $1.34 | $0.75 | $2.08 | $0.60 | |||
| Common Stock Dividends Per Share Declared | $1.28 | $1.37 | $1.49 | $1.22 | $1.20 | $1.24 | |||
| Common Stock Dividends Per Share Cash Paid | $1.28 | $1.37 | $1.49 | $1.22 | $1.20 | $1.24 | |||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Shares Authorized | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | ||||
| Preferred Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Asset Value Per Share | $13.26 | ||||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 106.0M | 107.8M | 107.9M | 107.9M | 106.9M | 103.7M | 101.0M | 100.9M | 100.9M | 100.8M | 100.6M | 98.4M | 96.9M |
| Common Stock Shares Outstanding | 104.2M | 106.9M | 107.9M | 107.9M | 107.9M | 106.3M | 101.4M | 100.9M | 100.9M | 100.9M | 100.7M | 99.5M | 96.9M |
| Weighted Average Number Of Diluted Shares Outstanding | 125.0M | 126.7M | 126.9M | 126.8M | 125.8M | 122.4M | 123.2M | 127.0M | 123.6M | 114.1M | 113.9M | 111.7M | 110.2M |
| Earnings Per Share Diluted | $0.11 | $0.07 | $0.22 | $0.22 | $0.31 | $0.26 | $0.27 | $0.32 | $0.40 | $0.08 | $0.16 | $0.34 | $0.22 |
| Earnings Per Share Basic | $0.11 | $0.07 | $0.22 | $0.22 | $0.32 | $0.26 | $0.28 | $0.35 | $0.44 | $0.08 | $0.16 | $0.37 | $0.23 |
| Common Stock Dividends Per Share Declared | $0.32 | $0.32 | $0.32 | $0.34 | $0.34 | $0.36 | $0.36 | $0.35 | $0.32 | $0.30 | $0.30 | $0.30 | $0.30 |
| Common Stock Dividends Per Share Cash Paid | $0.32 | $0.32 | $0.32 | $0.34 | $0.34 | $0.36 | $0.36 | $0.35 | $0.32 | $0.30 | $0.30 | $0.30 | $0.30 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Authorized | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | |||
| Preferred Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Investment Company Dividend Distribution | $124.3M | $151.4M | $132.0M | $117.7M | $120.8M | |
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $9.0K | $552.0K | $369.0K | $222.0K | $231.0K | |
| Stock Issued During Period Shares Period Increase Decrease | -5.2M | 5.3M | 1.6M | 3.0M | 1.1M | 0.00 |
| Stock Issued During Period Shares New Issues | 0.00 | 5.3M | 1.6M | 3.0M | 914.2K | 0.00 |
| Realized And Unrealized Gain Loss Investment And Derivative Operating Tax Expense Benefit | $409.0K | $2.1M | $1.3M | $8.5M | $114.0K | -$1.0M |
| Professional Fees | $4.6M | $4.4M | $3.8M | $3.4M | $3.2M | $3.5M |
| Net Investment Income | $136.4M | $146.2M | $160.3M | $120.4M | $119.0M | $117.4M |
| Management Fee Expense | $38.8M | $45.5M | $45.6M | $46.6M | $53.0M | $53.0M |
| Investment Income Operating Tax Expense Benefit | $21.0K | $262.0K | $418.0K | $825.0K | $118.0K | $22.0K |
| Investment Income Operating After Expense And Tax | $136.4M | $146.0M | $159.9M | $119.6M | $118.8M | $117.3M |
| Investment Income Investment Expense | $203.8M | $229.2M | $218.6M | $178.8M | $165.3M | $170.1M |
| Investment Company Expense After Reduction Of Fee Waiver And Reimbursement | $190.7M | $225.4M | $214.5M | $174.2M | $152.0M | $156.3M |
| Interest Income Operating Paid In Kind | $30.2M | $36.9M | $33.6M | $17.3M | $23.3M | $17.0M |
| Incentive Fee Expense | $30.8M | $36.4M | $38.3M | $29.9M | $29.7M | $29.2M |
| Gross Investment Income Operating | $327.1M | $371.7M | $374.8M | $294.6M | $271.0M | $273.7M |
| Foreign Currency Transaction Gain Loss Unrealized | $480.0K | -$606.0K | $100.0K | -$1.1M | -$81.0K | $0.00 |
| Dividend Income Operating Paid In Kind | $29.0M | $31.6M | $27.4M | $22.5M | $19.5M | $13.4M |
| Administrative Fees Expense | $4.2M | $4.2M | $4.1M | $4.1M | $4.5M | $4.4M |
| Investment Company Contractual Fee Waived | $13.1M | $3.7M | $4.1M | $4.4M | $13.1M | $12.8M |
| Unrealized Gain Loss Securities Repurchased Under Agreements To Resell | $0.00 | -$3.0M | -$39.0K | -$4.9M | $0.00 | $0.00 |
| Foreign Currency Transaction Gain Loss Realized | $0.00 | $420.0K | $13.0K | $827.0K | $15.0K | $0.00 |
| Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Price Change Operating Before Tax | -$162.1M | $15.1M | $10.4M | -$85.2M | $92.3M | |
| Realized Gain Loss Investment Derivative And Foreign Currency Transaction Price Change Operating Before Tax | $43.2M | -$41.4M | -$32.8M | $53.5M | -$3.8M | |
| Realized And Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax | -$119.4M | -$31.5M | -$23.8M | -$45.1M | $88.3M | |
| Other Noncash Income Expense | $60.7M | $70.1M | $61.5M | $40.0M | $50.4M | $37.5M |
| Interest Paid Net | $114.9M | $127.3M | $115.5M | $81.8M | $61.7M | $72.1M |
| Amortization Of Financing Costs | $8.8M | $9.8M | $6.8M | $6.8M | $7.4M | $4.9M |
| Securities Purchased Under Agreements To Resell Cost | $30.0M | $30.0M | $30.0M | $30.0M | $30.0M | |
| Securities Purchased Under Agreements To Resell | $13.5M | $13.5M | $16.5M | $16.5M | $21.4M | |
| Investment Owned At Fair Value | $2.74B | $3.09B | $3.01B | $3.22B | $3.17B |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment Company Dividend Distribution | $33.9M | $34.6M | $34.6M | $36.8M | $36.8M | $38.5M | $36.5M | $35.5M | $32.5M | $30.5M | $34.4M | $33.3M | $29.4M | $29.4M | $29.3M |
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $28.0K | $43.0K | $388.0K | $81.0K | $66.0K | $91.0K | $56.0K | $34.0K | $74.0K | $52.0K | |||||
| Stock Issued During Period Shares Period Increase Decrease | -2.7M | -924.7K | 0.00 | 0.00 | 1.6M | 3.7M | 502.6K | 0.00 | 0.00 | 220.1K | 1.2M | 1.6M | 0.00 | ||
| Stock Issued During Period Shares New Issues | 0.00 | 0.00 | 0.00 | 0.00 | 1.6M | 3.7M | 502.6K | 0.00 | 0.00 | 220.1K | 1.2M | 1.5M | 0.00 | ||
| Realized And Unrealized Gain Loss Investment And Derivative Operating Tax Expense Benefit | $25.0K | $21.0K | $22.0K | $1.0M | $130.0K | $637.0K | -$291.0K | $94.0K | $131.0K | -$30.0K | $155.0K | $2.0K | -$1.0K | ||
| Professional Fees | $924.0K | $1.1M | $1.4M | $1.0M | $1.1M | $1.1M | $850.0K | $1.0M | $965.0K | $775.0K | $817.0K | $937.0K | $923.0K | ||
| Net Investment Income | $34.1M | $34.6M | $34.6M | $35.5M | $38.7M | $37.6M | $40.0M | $40.9M | $38.5M | $32.8M | $31.6M | $30.0M | $30.6M | ||
| Management Fee Expense | $9.6M | $9.8M | $10.2M | $11.7M | $11.4M | $11.0M | $11.3M | $11.6M | $11.6M | $11.7M | $11.8M | $11.6M | $13.7M | ||
| Investment Income Operating Tax Expense Benefit | $29.0K | $8.0K | -$19.0K | $118.0K | $234.0K | $1.0K | -$627.0K | $932.0K | $96.0K | -$13.0K | -$87.0K | $95.0K | -$8.0K | ||
| Investment Income Operating After Expense And Tax | $34.0M | $34.6M | $34.6M | $35.4M | $38.4M | $37.6M | $40.7M | $39.9M | $38.4M | $32.8M | $31.7M | $29.9M | $30.6M | ||
| Investment Income Investment Expense | $51.0M | $51.5M | $52.9M | $60.8M | $56.8M | $53.9M | $55.3M | $55.7M | $54.5M | $46.8M | $42.6M | $40.3M | $41.6M | ||
| Investment Company Expense After Reduction Of Fee Waiver And Reimbursement | $46.5M | $48.9M | $51.0M | $59.8M | $55.9M | $53.0M | $54.3M | $54.6M | $53.5M | $45.7M | $41.5M | $39.0M | $37.8M | ||
| Interest Income Operating Paid In Kind | $7.6M | $6.9M | $7.6M | $9.1M | $9.0M | $9.7M | $7.9M | $7.9M | $9.0M | $6.2M | $7.3M | $8.5M | $5.7M | ||
| Incentive Fee Expense | $7.3M | $8.0M | $8.2M | $8.8M | $9.6M | $9.4M | $10.2M | $10.0M | $9.6M | $8.2M | $7.9M | $7.5M | $7.7M | ||
| Gross Investment Income Operating | $80.5M | $83.5M | $85.7M | $95.3M | $94.6M | $90.6M | $94.3M | $95.5M | $92.0M | $78.4M | $73.1M | $69.0M | $68.5M | ||
| Foreign Currency Transaction Gain Loss Unrealized | -$120.0K | $452.0K | $150.0K | $1.7M | $129.0K | -$23.0K | -$60.0K | $29.0K | $26.0K | -$10.0K | -$193.0K | -$422.0K | -$13.0K | ||
| Dividend Income Operating Paid In Kind | $7.3M | $6.6M | $8.2M | $8.3M | $7.7M | $7.4M | $7.0M | $6.7M | $6.5M | $6.0M | $5.3M | $5.1M | $3.7M | ||
| Administrative Fees Expense | $916.0K | $1.2M | $1.1M | $1.1M | $1.1M | $968.0K | $995.0K | $953.0K | $1.0M | $881.0K | $932.0K | $1.2M | $1.1M | ||
| Investment Company Contractual Fee Waived | $4.5M | $2.6M | $1.8M | $970.0K | $861.0K | $901.0K | $1.0M | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $3.8M | ||
| Unrealized Gain Loss Securities Repurchased Under Agreements To Resell | $0.00 | $0.00 | $0.00 | -$3.0M | $0.00 | -$39.0K | $0.00 | $0.00 | $0.00 | -$2.0M | $0.00 | ||||
| Foreign Currency Transaction Gain Loss Realized | $0.00 | -$1.5M | $0.00 | $0.00 | $0.00 | $1.0K | $12.0K | -$166.0K | $40.0K | $345.0K | $0.00 | ||||
| Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Price Change Operating Before Tax | -$21.7M | -$40.1M | -$48.9M | -$8.5M | $30.6M | $3.0M | -$16.9M | -$7.3M | $5.9M | -$24.9M | -$33.0M | -$10.4M | |||
| Realized Gain Loss Investment Derivative And Foreign Currency Transaction Price Change Operating Before Tax | $9.0K | $13.4M | $37.8M | -$2.0M | -$31.2M | -$11.8M | $4.7M | $2.6M | $677.0K | -$388.0K | $16.6M | $19.5M | |||
| Realized And Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax | -$21.7M | -$26.7M | -$11.1M | -$11.5M | -$3.7M | -$9.5M | -$12.0M | -$4.9M | $6.4M | -$25.3M | -$16.6M | $7.1M | |||
| Other Noncash Income Expense | $14.0M | $16.5M | $16.3M | $12.1M | |||||||||||
| Interest Paid Net | $27.1M | $25.4M | $27.8M | $23.7M | |||||||||||
| Amortization Of Financing Costs | $2.2M | $2.0M | $1.6M | $1.7M | |||||||||||
| Securities Purchased Under Agreements To Resell Cost | $30.0M | $30.0M | $30.0M | $30.0M | $30.0M | $30.0M | $30.0M | $30.0M | $30.0M | $30.0M | |||||
| Securities Purchased Under Agreements To Resell | $13.5M | $13.5M | $13.5M | $13.5M | $13.5M | $16.5M | $16.5M | $16.5M | $16.5M | $19.4M | |||||
| Investment Owned At Fair Value | $2.94B | $3.00B | $3.03B | $3.27B | $3.21B | $3.07B | $3.11B | $3.18B | $3.27B | $3.23B |
Most recent annual filing with the SEC: February 24, 2026
Data sourced from SEC EDGAR public filings as of August 10, 2026.